Could less radiation be enough for HPV throat cancer?

NCT ID NCT06554158

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is for people with HPV-positive oropharyngeal (throat) cancer who have had surgery. Researchers want to see if giving a lower dose of radiation to a smaller area (just the neck, not the original tumor site) works as well as the standard higher dose. The goal is to reduce side effects while still controlling the cancer. About 30 participants will receive this de-escalated radiation therapy and be followed for two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiation therapy (lower dose, smaller field)
What this could lead to
If successful, this could allow many patients with HPV-positive throat cancer to receive less radiation, reducing long-term side effects like swallowing problems and dry mouth.
What could go wrong
This is a small, early-phase study with only 30 participants, so results may not apply to everyone. There is a risk that lower-dose radiation might not control the cancer as well as standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medstar Georgetown University Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.